NCT06711913View on ClinicalTrials.gov

Role of Intravenous Dexmedetomidine in Reducing Shivering After Shivering Cesarean Section Due to Spinal Anesthesia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 21, 2023

Primary Completion Date

June 15, 2024

Study Completion Date

June 21, 2024

Conditions

Shivering

Interventions

DRUG

Dexmedetomidine

intravenous dexmedetomidine given in form of 100ml infusion over 10 minutes

OTHER

Normal Saline (Placebo)

control group receive normal saline as placebo

Trial Locations (1)

Unknown

Liaquat National Hospital and Medical College, Karachi

All Listed Sponsors

lead

Liaquat National Hospital & Medical College

OTHER

NCT06711913 - Role of Intravenous Dexmedetomidine in Reducing Shivering After Shivering Cesarean Section Due to Spinal Anesthesia | Biotech Hunter | Biotech Hunter